| Line Item | 2022-12-29 | Y/Y |
|---|---|---|
| Revenue | $249.2M | +117.5% |
| R&D Expense | $4.6M | +170.6% |
| SG&A Expense | $44.3M | +23.1% |
| Operating Income | $6.9M | +110.1% |
| Interest Expense | $79.7M | +23.0% |
| Pre-tax Income | -$66.2M | +44.1% |
| Income Tax | $0 | — |
| Net Income | -$28.7M | +41.1% |
| EPS (Basic) | -$0.35 |
| Line Item | 2022-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.7M | -39.0% |
| Short-term Investments | $700K | +133.3% |
| Accounts Receivable | $92.0M | +73.6% |
| Current Assets | $164.4M | +3.8% |
| Total Assets | $792.4M | -3.1% |
| Current Liabilities | $1.20B | +1623.6% |
| Long-term Debt | $1.12B | +2.2% |
| Line Item | 2022-12-29 | Y/Y |
|---|---|---|
| Capital Expenditures | $2.9M | -49.1% |
| +42.6% |
| EPS (Diluted) | -$0.35 | +42.6% |
| Total Liabilities |
| $1.26B |
| +4.6% |
| Stockholders' Equity | -$515.3M | +2.2% |